Icon

CIBINQO (nda213871)- (50MG,100MG,200MG)

ABROCITINIB PFIZER
50MG,100MG,200MG
No No
2034-Feb-19 2027-Jan-14
None None
None No
CIBINQO is a Janus kinase (JAK) inhibitor indicated for the treatment of adults with refractory, moderate-to-severe atopic dermatitis whose disease is not adequately controlled with other systemic drug products, including biologics, or when use of those therapies is inadvisable.
0 0 0
Total Other Developers 4
Drugs with Suitability No
50MG ** ** - - -
100MG ** ** - - -
200MG ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.